Soysal, T. Et Al. 2019. The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.19, no.7 .

Soysal, T., Eskazan, A. E., Serin, I., Sadri, S., Keskin, D., Yurttas, N. O., ... Berk, S.(2019). The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.19, no.7.

Soysal, Teoman Et Al. "The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.19, no.7, 2019

Soysal, Teoman Et Al. "The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.19, no.7, 2019

Soysal, T. Et Al. (2019) . "The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.19, no.7.

@article{article, author={Teoman Soysal Et Al. }, title={The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2019}